Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Orchestra BioMed Holdings (OBIO) Assets Average (2022 - 2025)

Historic Assets Average for Orchestra BioMed Holdings (OBIO) over the last 4 years, with Q3 2025 value amounting to $73.8 million.

  • Orchestra BioMed Holdings' Assets Average fell 4.74% to $73.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $73.8 million, marking a year-over-year decrease of 4.74%. This contributed to the annual value of $85.7 million for FY2024, which is 1016.8% down from last year.
  • According to the latest figures from Q3 2025, Orchestra BioMed Holdings' Assets Average is $73.8 million, which was down 4.74% from $50.9 million recorded in Q2 2025.
  • Over the past 5 years, Orchestra BioMed Holdings' Assets Average peaked at $161.6 million during Q2 2022, and registered a low of $50.9 million during Q2 2025.
  • Moreover, its 4-year median value for Assets Average was $85.5 million (2022), whereas its average is $95.8 million.
  • In the last 5 years, Orchestra BioMed Holdings' Assets Average surged by 2883.18% in 2023 and then tumbled by 4087.25% in 2024.
  • Over the past 4 years, Orchestra BioMed Holdings' Assets Average (Quarter) stood at $82.1 million in 2022, then rose by 28.83% to $105.8 million in 2023, then dropped by 28.4% to $75.7 million in 2024, then fell by 2.55% to $73.8 million in 2025.
  • Its Assets Average stands at $73.8 million for Q3 2025, versus $50.9 million for Q2 2025 and $67.6 million for Q1 2025.